Uli Hacksell

7.3k total citations · 2 hit papers
193 papers, 5.9k citations indexed

About

Uli Hacksell is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Uli Hacksell has authored 193 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 79 papers in Organic Chemistry and 70 papers in Cellular and Molecular Neuroscience. Recurrent topics in Uli Hacksell's work include Receptor Mechanisms and Signaling (63 papers), Neurotransmitter Receptor Influence on Behavior (41 papers) and Pharmacological Receptor Mechanisms and Effects (25 papers). Uli Hacksell is often cited by papers focused on Receptor Mechanisms and Signaling (63 papers), Neurotransmitter Receptor Influence on Behavior (41 papers) and Pharmacological Receptor Mechanisms and Effects (25 papers). Uli Hacksell collaborates with scholars based in Sweden, United States and Netherlands. Uli Hacksell's co-authors include Jonas Nilsson, Arvid Carlsson, Stephan Hjorth, Per Lindberg, G. Doyle Daves, L. -E. Arvidsson, Domènec J. Sánchez, Kristina Luthman, Anette M. Johansson and Mark R. Brann and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Uli Hacksell

189 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity

1982 472 citations Stephan Hjorth, Uli Hacksell et al. Journal of Neural Transmission profile →
Effects of a new type of 5-HT receptor agonist on male rat sexual behavior

1981 262 citations Stephan Hjorth, Uli Hacksell et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Uli Hacksell	2.8k	2.8k	1.7k	676	496	193	5.9k
Antonio Lucacchini	2.3k 0.8×	1.1k 0.4×	1.4k 0.8×	495 0.7×	452 0.9×	368	5.9k
B. Kenneth Koe	1.7k 0.6×	2.5k 0.9×	916 0.6×	321 0.5×	546 1.1×	79	4.7k
C. Bræstrup	2.6k 0.9×	4.2k 1.5×	678 0.4×	484 0.7×	335 0.7×	55	5.8k
Josée E. Leysen	3.4k 1.2×	3.7k 1.3×	416 0.3×	625 0.9×	500 1.0×	127	6.4k
Robert F. Bruns	3.7k 1.3×	2.5k 0.9×	898 0.5×	275 0.4×	424 0.9×	64	6.7k
Lee E. Schechter	2.3k 0.8×	2.6k 0.9×	849 0.5×	331 0.5×	672 1.4×	95	5.3k
Thomas A. Pugsley	2.2k 0.8×	1.9k 0.7×	1.2k 0.7×	318 0.5×	377 0.8×	98	4.4k
John L. Neumeyer	2.8k 1.0×	3.7k 1.4×	1.3k 0.8×	380 0.6×	474 1.0×	270	7.0k
Pier Luigi Canonico	2.7k 1.0×	2.0k 0.7×	1.1k 0.7×	456 0.7×	546 1.1×	213	7.0k
Maarten E. A. Reith	4.8k 1.7×	6.1k 2.2×	581 0.3×	576 0.9×	737 1.5×	241	8.7k

Countries citing papers authored by Uli Hacksell

Since Specialization

Citations

This map shows the geographic impact of Uli Hacksell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uli Hacksell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uli Hacksell more than expected).

Fields of papers citing papers by Uli Hacksell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uli Hacksell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uli Hacksell. The network helps show where Uli Hacksell may publish in the future.

Co-authorship network of co-authors of Uli Hacksell

This figure shows the co-authorship network connecting the top 25 collaborators of Uli Hacksell. A scholar is included among the top collaborators of Uli Hacksell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uli Hacksell. Uli Hacksell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehmann, Fredrik, Erika A. Currier, Roger Olsson, Uli Hacksell, & Kristina Luthman. (2005). Isochromanone-based urotensin-II receptor agonists. Bioorganic & Medicinal Chemistry. 13(8). 3057–3068. 26 indexed citations

Weiner, David M., Herbert Y. Meltzer, Isaac Veinbergs, et al.. (2004). The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine. Psychopharmacology. 177(1-2). 207–216. 206 indexed citations

Alder, Janet, Uli Hacksell, & Philip G. Strange. (2003). Analysis of molecular determinants of affinity and relative efficacy of a series of R‐ and S‐2‐(dipropylamino)tetralins at the 5‐HT_1A serotonin receptor. British Journal of Pharmacology. 138(6). 1129–1139. 5 indexed citations

Luthman, Kristina, et al.. (2003). Synthesis and Use of Pseudopeptides Derived from 1,2,4-Oxadiazole-, 1,3,4-0xadiazole-, and 1,2,4-Triazole-based Dipeptidomimetics. Humana Press eBooks. 23. 1–24. 5 indexed citations

Hacksell, Uli, Norman Nash, Ethan S. Burstein, et al.. (2002). Chemical genomics: massively parallel technologies for rapid lead identification and target validation. Cytotechnology. 38(1-3). 3–10. 4 indexed citations

Hacksell, Uli, et al.. (1999). Investigating mechanisms of agonist action at the human D-2short dopamine receptor. British Journal of Pharmacology. 126. 109. 1 indexed citations

Nomikos, George G., et al.. (1996). The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. Journal of Neural Transmission. 103(5). 541–554. 24 indexed citations

Johansson, Gary, et al.. (1995). 3-Heteroaryl-Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists. Synthesis and Structure-Activity Relationships. Journal of Medicinal Chemistry. 38(3). 473–487. 21 indexed citations

Malmberg, Åsa, Gunnar Nordvall, Anna‐Karin Johansson, Nina Mohell, & Uli Hacksell. (1994). Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.. Molecular Pharmacology. 46(2). 299–312. 41 indexed citations

10.

Liu, Ye, et al.. (1993). Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors. Journal of Medicinal Chemistry. 36(26). 4221–4229. 25 indexed citations

11.

Nilsson, Björn M., Peter de Boer, Cor J. Grol, & Uli Hacksell. (1992). An improved synthesis of the enantiomers of bm‐5 and their effects on the central in vivo release of acetylcholine. Chirality. 4(6). 367–376. 2 indexed citations

12.

Cornfield, Linda J., et al.. (1991). Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.. Journal of Pharmacology and Experimental Therapeutics. 258(1). 58–65. 94 indexed citations

13.

Lindgren, Silvana, et al.. (1991). (S)-UH-301 antagonizes (R)-8-OH-DPAT-indiiced cardiovascular effects in the rat. European Journal of Pharmacology. 199(3). 367–370. 17 indexed citations

14.

Karlsson, Anders, et al.. (1990). (R)‐ and (S)‐5‐hydroxy‐2‐(dipropylamino)tetralin (5‐OH DPAT): Assessment of optical purities and dopaminergic activities. Chirality. 2(2). 90–95. 27 indexed citations

15.

Nelson, D L, et al.. (1989). Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain. Journal of Medicinal Chemistry. 32(4). 779–783. 51 indexed citations

16.

Hjorth, Stephan, Trevor Sharp, & Uli Hacksell. (1989). Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3. European Journal of Pharmacology. 170(3). 269–274. 7 indexed citations

17.

Ringdahl, Björn, et al.. (1989). Conformationally restricted analogs of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Journal of Medicinal Chemistry. 32(4). 863–869. 10 indexed citations

18.

Mellin, Charlotta, Anders Karlén, Anette M. Johansson, et al.. (1988). Central dopaminergic and 5-hydroxytryptaminergic effects of C(3)-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin. Journal of Medicinal Chemistry. 31(6). 1130–1140. 15 indexed citations

19.

Mellin, Charlotta, et al.. (1987). Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors. European Journal of Pharmacology. 143(1). 55–63. 8 indexed citations

20.

Svensson, U, Uli Hacksell, & Richard Dahlbom. (1978). Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(1). 67–70. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact